<DOC>
	<DOCNO>NCT02581709</DOCNO>
	<brief_summary>The goal research study test feasibility intervention programme reduce cognitive impairment due cancer treatment . The investigator want find acceptable intervention procedure cancer patient .</brief_summary>
	<brief_title>An Intervention Programme Reduce Cognitive Impairment Due Cancer</brief_title>
	<detailed_description>The intervention programme consist follow component : education cancer-related cognitive impairment , relaxation technique , compensatory technique , goal-setting lifestyle advice . Each session last 90 120 minute , week six week . The intervention deliver group set , non-clinical environment investigator . The investigator aim recruit 54 cancer patient local Cancer Centre onto study . The cognitive functioning cancer patient due start chemotherapy assess . Each patient 's cognitive function reassess completion chemotherapy additional self-report measure administer . Patients demonstrate cognitive decline course chemotherapy invite take part intervention programme . All patient give information sheet advise contact member health-care team notice change cognitive function . The investigator aim take 30 patient intervention . At end intervention , participant complete intervention evaluation questionnaire addition cognitive functioning assessment self-report measure .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Aged &gt; 18 year Have diagnosis early stage breast colorectal cancer ( Stage IIII disease ) Are plan receive standard care adjuvant chemotherapy . Able complete Neuropsychological test assessment pre post chemotherapy receipt . Proficiency English language Able provide inform consent Patients breast cancer receive standard care hormonal therapy radiotherapy Treatment plan include chemotherapy . Diagnosed metastatic cancer Treatment plan include cranial radiation , brain surgery intrathecal therapy . History previous cancer , previous treatment experience may contribute cognitive impairment ( exception nonmelanoma skin cancer ) . History cranial radiation , brain surgery intrathecal therapy due direct impact brain . History , , comorbid condition may alter cognitive function test i.e . stroke , head injury , epilepsy , Parkinson 's disease , Huntington 's disease , Alzheimer 's disease , encephalitis , substance abuse , bipolar disorder , psychosis , schizophrenia learn disability . Current use psychostimulant medication e.g . Methylphenidate increase activity central nervous system , central nervous system ( CNS ) depressant medication e.g . Benzodiazepines Barbiturates due slow cognitive process . Use commonly prescribe antidepressant e.g . Monoamine Oxidase Inhibitors ( MAOIs ) , Selective Serotonin Reuptake Inhibitors ( SSRIs ) Serotonin Noradrenaline Reuptake Inhibitors ( SNRIs ) Tricyclic Antidepressants ( TCAs ) permit . Have MiniMental Status Examination score â‰¤23 indicative substantial cognitive impairment include dementia . Current uncontrolled mood disorder e.g . Major depression .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Feasibility study</keyword>
	<keyword>Cognition</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Neoplasms</keyword>
</DOC>